Back to search

CK8/18 expression, the basal phenotype, and family history in identifying BRCA1‐associated breast cancer in the Ontario site of the Breast Cancer Family Registry

Data up to Jan 2025

Published2010
Citations15
References50

Total Citations Per Year

Abstract

References (50)

Estimating the Dimension of a Model

1978 • 43,634 citations

Gene expression profiling predicts clinical outcome of breast cancer

2002 • 9,314 citations

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

2005 • 6,083 citations

A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1

1994 • 5,994 citations

Repeated observation of breast tumor subtypes in independent gene expression data sets

2003 • 5,356 citations

The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells

1982 • 5,272 citations

A note on a general definition of the coefficient of determination

1991 • 5,067 citations

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

2005 • 4,715 citations

Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

2004 • 2,644 citations

Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

2003 • 2,170 citations

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1998 • 2,121 citations

Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

1999 • 1,991 citations

Cancer Susceptibility and the Functions of BRCA1 and BRCA2

2002 • 1,676 citations

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

2009 • 1,390 citations

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

2005 • 1,037 citations

Keratin expression in human tissues and neoplasms

2002 • 809 citations

The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2

2002 • 809 citations

Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history.

1993 • 796 citations

Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 Mutations

1998 • 695 citations

Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients.

1994 • 622 citations

Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

2005 • 610 citations

Breast and Ovarian Cancer

2003 • 605 citations

Expression of luminal and basal cytokeratins in human breast carcinoma

2004 • 593 citations

Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast Cancer

2008 • 575 citations

BRCA1 regulates human mammary stem/progenitor cell fate

2008 • 448 citations

Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement

2005 • 404 citations

Common Adult Stem Cells in the Human Breast Give Rise to Glandular and Myoepithelial Cell Lineages: A New Cell Biological Concept

2002 • 284 citations

Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study

2004 • 283 citations

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆

2007 • 253 citations

Software Tools for High-Throughput Analysis and Archiving of Immunohistochemistry Staining Data Obtained with Tissue Microarrays

2002 • 202 citations

Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors

2005 • 194 citations

BRCA1 functions as a breast stem cell regulator

2004 • 168 citations

Pretest Prediction of BRCA1 or BRCA2 Mutation by Risk Counselors and the Computer Model BRCAPRO

2002 • 151 citations

Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells

2005 • 141 citations

Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept

2003 • 140 citations

Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc Committee

1998 • 136 citations

Optimal Selection of Individuals for BRCA Mutation Testing: A Comparison of Available Methods

2006 • 119 citations

Genetic epidemiology of BRCA mutations – family history detects less than 50% of the mutation carriers

2007 • 118 citations

Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer.

2000 • 84 citations

Comparison of DNA- and RNA-Based Methods for Detection of TruncatingBRCA1 Mutations

2002 • 78 citations

em BRCA1 em in cancer cell cycle and genomic stability

2003 • 73 citations

Comparison of HER2/neuStatus Assessed by Quantitative Polymerase Chain Reaction and Immunohistochemistry

2001 • 67 citations

Morphology of Breast Cancer as a Means of Triage of Patients for BRCA1 Genetic Testing

2006 • 44 citations

Prognostic Effect of Basal-Like Breast Cancers Is Time Dependent: Evidence from Tissue Microarray Studies on a Lymph Node–Negative Cohort

2008 • 39 citations

Why are the majority of hereditary cases of early-onset breast cancer sporadic? A simulation study.

2000 • 35 citations

Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients.

2001 • 33 citations

Novel consensus DNA‐binding sequence for BRCA1 protein complexes

2003 • 32 citations

Histopathological criteria and selection algorithms for BRCA1 genetic testing

2009 • 16 citations

The pathology of familial breast cancer: Clinical and geneticcounselling implications of breast cancer pathology

1999 • 13 citations

Individual and family characteristics associated with protein truncating BRCA1 and BRCA2 mutations in an Ontario population based series from the Cooperative Family Registry for Breast Cancer Studies

2003 • 12 citations

Cited By (0)

No citing papers found in database

CK8/18 expression, the basal phenotype, and family history in identifying… (2010) – Cancer | Metascience Observatory Explorer